Developer docs
API playgroundTry for free, no card

Search company profiles

Central Lab

Full company profile

uuid0043zc4

Namestring
Central Lab
Legal namestring
CENTRAL CLINICAL AND MOLECULAR GENETICS LABORATORIES S.A. (CENTRAL LABORATORIES ΙΔΙΩΤΙΚΟ ΠΟΛΥΪΑΤΡΕΙΟ ΙΔΙΩΤΙΚΑ ΔΙΑΓΝΩΣΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ)
Websiteurl
centrallab.gr
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Central Lab (legal entity: CENTRAL CLINICAL AND MOLECULAR GENETICS LABORATORIES S.A.) is a privately held clinical diagnostic laboratory headquartered in Nea Chalkidona, Attica, Greece, founded in 2015. The company operates a single accredited facility organized into eight specialized departments — Microbiology, Biochemistry, Hematology, Cytology, Hormonology, Immunology/Virology, Molecular Biology (with a Biosafety Level II genetics laboratory), and Allergy Testing — supported by a fully automated robotic pipeline (pre-analytical, analytical, post-analytical) using analyzers from SIEMENS, ROCHE, BIORAD, SEBIA, SNIBE, EUROIMMUN, and THERMO FISHER SCIENTIFIC/Phadia (including the ImmunoCAP reference method). It holds ISO 15189:2022 (Certificate No. 994), ISO 9001:2015, and ISO/IEC 27001:2022 certifications.

The company generates revenue primarily through per-test fees on a transaction model. Pricing for COVID-19 tests is government-regulated (€7 antigen, €35 RT-PCR), while broader diagnostic pricing is positioned as competitive. Its go-to-market is a hybrid B2B/B2C model: a partner-network B2B motion serves medical diagnostic centers, microbiology laboratories, university clinics, hospital research centers, pharmaceutical companies, and CROs for clinical trial laboratory services via sample pickup using its own refrigerated UN3373-compliant fleet and a computerized partner interface; a direct-to-consumer motion offers walk-in testing at the Nea Chalkidona facility (Monday–Friday 08:00–21:00, Saturday 09:00–17:00) and on-site workplace sampling for corporate clients. Leadership consists of CEO and President Anastasia Kotsigianni. The company is part of the IATRIKI DIAGNOSI GROUP (ΟΜΙΛΟΣ ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ) network.

Short descriptiontext

Central Lab is a privately held, ISO 15189-accredited clinical diagnostic laboratory in Nea Chalkidona, Greece, serving partner medical centers, hospitals, CROs, pharmaceutical companies, corporate employers, and walk-in patients with automated robotic testing across eight laboratory disciplines.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNea Chalkidona, Greece
HQ citystring
Nea Chalkidona
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, diagnostic testing, medical laboratory diagnostics, molecular genetics testing, pathology services
Industry4 codes
1Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryYes
2Reference & Esoteric Testing Laboratories
CodeHLAFAMAJPrimaryNo
3Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryNo
4Microbiology & Infectious Disease Testing Laboratories
CodeHLAFAMADPrimaryNo
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Diagnostic Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Laboratory Diagnostic Testing
TypeTransaction Fee
Description

Laboratory diagnostic testing services for clinical samples including microbiology, biochemistry, hematology, cytology, molecular biology, immunology, and allergy testing. Revenue generated from individual test fees and package testing services.

centrallab.gr
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details6 tiers
1Rapid Antigen Test (COVID-19)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€7 per test - government regulated price

centrallab.gr
2RT-PCR Molecular Test (COVID-19)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€35 per test - government regulated price per ministerial decision 657/2022

centrallab.gr
3Antibody Testing Panel (COVID-19)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€60 for full panel (IgG, IgM, IgA); individual: IgA €25, IgM €20, IgG €20

centrallab.gr
4Neutralizing Antibodies (COVID-19)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€20 per test

centrallab.gr
5Cellular Immunity Test (COVID-19)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€80 per test

centrallab.gr
6Corporate/Workplace Testing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Mass sampling available at workplaces at preferential rates

centrallab.gr
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Central Lab is a private clinical and molecular genetics laboratory in Greece offering diagnostic testing across microbiology, biochemistry, hematology, cytology, hormonology, immunology/virology, molecular biology, and allergy disciplines, supported by automated robotic analyzers and a Biosafety II molecular genetics department. It serves as a reference laboratory to partner diagnostic centers, university clinics, microbiology labs, pharmaceutical companies, and CROs through refrigerated sample transport, and also provides direct walk-in testing to individual patients including comprehensive COVID-19 services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Fast turnaround times achieved through automated robotic systems and computerized interface with partner laboratories
+1 more record
Product overview1 text field

Central Lab operates as a unified diagnostic laboratory offering comprehensive medical laboratory services across multiple specialized departments. The core portfolio includes Microbiology, Biochemistry, Hematology, Cytology, Hormonology, Immunology/Virology, Molecular Biology, and Allergy Testing departments. COVID-19 testing services (RT-PCR, rapid antigen, antibody, and cellular immunity testing) represent a major service addition. The laboratory also provides sample transportation with refrigerated vehicles. All departments operate under ISO 9001:2015 and ISO 15189:2012/2022 accreditation standards with automated robotic systems for high reliability testing.

Product and service10 records
1Microbiology Testing
CategoryLaboratory Service
Description

Microbiological diagnosis of causes of infectious diseases using modern techniques following international quality standards set by CLSI, EUCAST, and WHO.

2Biochemistry / Clinical Chemistry Testing
CategoryLaboratory Service
Description

Automated clinical chemistry testing using modern high-specification technology systems ensuring speed and reliability across the full spectrum of clinical chemistry analyses.

3Hematology Testing
CategoryLaboratory Service
Description

Hematological testing using automatic analyzers and coagulation analyzers with high-performance liquid chromatography (HPLC) as reference method, ensuring high reliability particularly important in clinical diagnosis.

4Cytology Testing
CategoryLaboratory Service
Description

Cytological examinations including PAP test and thin Prep vaginal/endocervical smears, urine cytology, sputum cytology, breast secretions, and fine needle aspiration (FNA) of the thyroid.

5Hormonology Testing
CategoryLaboratory Service
Description

Hormonal analyses for monitoring normal function of endocrine glands and diseases related to them, executed in high daily volumes.

6Immunology / Virology Testing
CategoryLaboratory Service
Description

Diagnostic immunology and virology testing using modern equipment and techniques including immunofluorescence, ELISA, nephelometry, immunochromatography, and agglutination reactions.

7Molecular Biology Testing
CategoryLaboratory Service
Description

Specialized diagnostic tests in a fully equipped Molecular Genetics Department with Biosafety Level II classification, covering prevention, predisposition investigation, early diagnosis, and monitoring of hereditary and infectious diseases.

8Allergy Testing
CategoryLaboratory Service
Description

Allergen testing using the ImmunoCAP reference method from Phadia Laboratory Systems for precise allergy diagnostics.

9COVID-19 Testing Services
CategoryDiagnostic Service
Description

Comprehensive COVID-19 testing including RT-PCR molecular testing, rapid antigen testing, antibody testing (IgG, IgM, IgA), neutralizing antibody detection, and cellular immunity testing for SARS-CoV-2.

10Sample Transportation Service
CategorySupport Service
Description

Transportation of biological samples using company-owned vehicles with refrigerated chambers following UN3373 safety transport rules, supporting partner laboratory and clinic network operations.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeTechnology or Integration
Description

Equipment manufacturer partnership for medical technology analyzers. SIEMENS provides laboratory diagnostic equipment supporting the lab's automated testing capabilities.

Strategic tierCoreTypeTechnology or Integration
Description

Equipment manufacturer partnership for medical technology analyzers. ROCHE provides diagnostic systems for clinical chemistry and other testing.

Strategic tierCoreTypeTechnology or Integration
Description

Equipment and quality control supplier. Provides analyzers and external quality control protocols (BIORAD, UK NEQAS, INSTAND EV).

Strategic tierCoreTypeTechnology or Integration
Description

Equipment manufacturer partnership for medical technology analyzers for electrophoresis and hemoglobin testing.

Strategic tierCoreTypeTechnology or Integration
Description

Equipment manufacturer partnership for medical technology analyzers.

Strategic tierCoreTypeTechnology or Integration
Description

Equipment manufacturer partnership for autoimmune and infectious disease testing systems.

Strategic tierCoreTypeTechnology or Integration
Description

Equipment manufacturer partnership for laboratory technology solutions including allergy testing (ImmunoCAP via Phadia).

Strategic tierCoreTypeTechnology or Integration
Description

Provider of ImmunoCAP reference method for allergy testing - the gold standard for allergen-specific IgE testing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical research organizations collaborating with Central Lab for phase I-IV clinical trials. Lab provides specialized testing including ISO15189 accredited analyses.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Greek and multinational pharmaceutical companies engaged in clinical research partnerships with Central Lab for laboratory diagnostic services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Greek hospital research centers collaborating on clinical studies requiring specialized laboratory testing.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Network of medical diagnostic centers referring samples to Central Lab for specialized testing. Computerized interface for seamless operations.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partner microbiology labs referring samples for specialized testing. Includes use of modern techniques per CLSI, EUCAST, WHO standards.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Academic medical center partners requiring specialized laboratory diagnostics and research support.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Pan-European diagnostics and outpatient imaging operator with significant Greek presence. Comparable in offering clinical lab and imaging services but operates at much larger scale and as part of a multinational platform.

TypeDirect peer
Description

Greek diagnostic laboratory network offering routine and specialized clinical testing with partner sample collection across multiple regions. Comparable operating model with broader geographic coverage and consumer brand recognition.

TypeDirect peer
Description

Largest Greek diagnostic laboratory chain offering clinical chemistry, microbiology, immunology, and molecular testing with extensive partner network and multi-region footprint. Directly comparable business model (central lab + partner sample collection) but with significantly greater scale and geographic reach.

TypeBroad incumbent
Description

Europe's largest clinical laboratory services provider with presence across multiple European markets. Comparable in core reference laboratory services, clinical trial central lab work, and broad test catalog — but operating at vastly greater scale.

TypeBroad incumbent
Description

Global clinical diagnostics and specialty testing group. Comparable in offering esoteric reference testing, clinical trial support, and infectious disease diagnostics, though as part of a much larger international testing platform.

TypeBroad incumbent
Description

Greek healthcare group operating diagnostic laboratories, clinics, and hospitals. Comparable in providing central lab services to partner sites and direct patients but within a broader healthcare delivery portfolio.

TypeBroad incumbent
Description

Major European clinical diagnostics and specialty testing provider. Comparable in offering routine and esoteric testing, clinical trial central lab services, and partner-based sample collection, though with broader European footprint.

TypeRegional player
Description

Hospital-based diagnostic laboratory in Cyprus with comparable service scope (biochemistry, microbiology, immunology, molecular biology). Regionally adjacent rather than directly competing, useful as a Southern EU/Mediterranean peer reference for Central Lab's clinical trial ambitions.

TypeDirect peer
Description

Greek diagnostic laboratory offering a broad test catalog and partner network model similar to Central Lab. Directly comparable in scale and Attica focus, with similar mix of clinical chemistry, immunology, and molecular testing.

TypeDirect peer
Description

Athens-based diagnostic laboratory providing comprehensive clinical testing services including biochemistry, microbiology, hematology, and molecular diagnostics. Closest peer in geographic focus and service scope within the Attica market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Central Lab

Clinical Diagnostic Laboratory Servicescentrallab.gr

Central Lab is a privately held, ISO 15189-accredited clinical diagnostic laboratory in Nea Chalkidona, Greece, serving partner medical centers, hospitals, CROs, pharmaceutical companies, corporate employers, and walk-in patients with automated robotic testing across eight laboratory disciplines.

What Central Lab does

Central Lab (legal entity: CENTRAL CLINICAL AND MOLECULAR GENETICS LABORATORIES S.A.) is a privately held clinical diagnostic laboratory headquartered in Nea Chalkidona, Attica, Greece, founded in 2015. The company operates a single accredited facility organized into eight specialized departments — Microbiology, Biochemistry, Hematology, Cytology, Hormonology, Immunology/Virology, Molecular Biology (with a Biosafety Level II genetics laboratory), and Allergy Testing — supported by a fully automated robotic pipeline (pre-analytical, analytical, post-analytical) using analyzers from SIEMENS, ROCHE, BIORAD, SEBIA, SNIBE, EUROIMMUN, and THERMO FISHER SCIENTIFIC/Phadia (including the ImmunoCAP reference method). It holds ISO 15189:2022 (Certificate No. 994), ISO 9001:2015, and ISO/IEC 27001:2022 certifications.

The company generates revenue primarily through per-test fees on a transaction model. Pricing for COVID-19 tests is government-regulated (€7 antigen, €35 RT-PCR), while broader diagnostic pricing is positioned as competitive. Its go-to-market is a hybrid B2B/B2C model: a partner-network B2B motion serves medical diagnostic centers, microbiology laboratories, university clinics, hospital research centers, pharmaceutical companies, and CROs for clinical trial laboratory services via sample pickup using its own refrigerated UN3373-compliant fleet and a computerized partner interface; a direct-to-consumer motion offers walk-in testing at the Nea Chalkidona facility (Monday–Friday 08:00–21:00, Saturday 09:00–17:00) and on-site workplace sampling for corporate clients. Leadership consists of CEO and President Anastasia Kotsigianni. The company is part of the IATRIKI DIAGNOSI GROUP (ΟΜΙΛΟΣ ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ) network.

Central Lab firmographics

Firmographics
Name
Central Lab
Legal name
CENTRAL CLINICAL AND MOLECULAR GENETICS LABORATORIES S.A. (CENTRAL LABORATORIES ΙΔΙΩΤΙΚΟ ΠΟΛΥΪΑΤΡΕΙΟ ΙΔΙΩΤΙΚΑ ΔΙΑΓΝΩΣΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ)
Website
https://centrallab.gr
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Central Lab is a privately held, ISO 15189-accredited clinical diagnostic laboratory in Nea Chalkidona, Greece, serving partner medical centers, hospitals, CROs, pharmaceutical companies, corporate employers, and walk-in patients with automated robotic testing across eight laboratory disciplines.
Ownership category
akta.pro rank

Central Lab industry classification

Industry
Product category
Clinical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Clinical Research & Trial Central Laboratories (HLAFAMAL)
akta.pro secondary industries
Reference & Esoteric Testing Laboratories (HLAFAMAJ), Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

Keywords

  • Clinical laboratory services
  • Diagnostic testing
  • Medical laboratory diagnostics
  • Molecular genetics testing
  • Pathology services

Where Central Lab is headquartered

Location

Headquarters

HQ city
Nea Chalkidona
HQ country
Greece
HQ region
Europe

Offices1 record

Markets served

Central Lab business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Clinical Laboratory Diagnostic Testing: Laboratory diagnostic testing services for clinical samples including microbiology, biochemistry, hematology, cytology, molecular biology, immunology, and allergy testing. Revenue generated from individual test fees and package testing services.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goRapid Antigen Test (COVID-19)
Unit PricingPay-as-you-goRT-PCR Molecular Test (COVID-19)
Unit PricingPay-as-you-goAntibody Testing Panel (COVID-19)
Unit PricingPay-as-you-goNeutralizing Antibodies (COVID-19)
Unit PricingPay-as-you-goCellular Immunity Test (COVID-19)
Unit PricingPay-as-you-goCorporate/Workplace Testing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Central Lab product offering

Product offering

Core offering

Central Lab is a private clinical and molecular genetics laboratory in Greece offering diagnostic testing across microbiology, biochemistry, hematology, cytology, hormonology, immunology/virology, molecular biology, and allergy disciplines, supported by automated robotic analyzers and a Biosafety II molecular genetics department. It serves as a reference laboratory to partner diagnostic centers, university clinics, microbiology labs, pharmaceutical companies, and CROs through refrigerated sample transport, and also provides direct walk-in testing to individual patients including comprehensive COVID-19 services.

Product overview

Central Lab operates as a unified diagnostic laboratory offering comprehensive medical laboratory services across multiple specialized departments. The core portfolio includes Microbiology, Biochemistry, Hematology, Cytology, Hormonology, Immunology/Virology, Molecular Biology, and Allergy Testing departments. COVID-19 testing services (RT-PCR, rapid antigen, antibody, and cellular immunity testing) represent a major service addition. The laboratory also provides sample transportation with refrigerated vehicles. All departments operate under ISO 9001:2015 and ISO 15189:2012/2022 accreditation standards with automated robotic systems for high reliability testing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Microbiology Testing Microbiological diagnosis of causes of infectious diseases using modern techniques following international quality standards set by CLSI, EUCAST, and WHO.
  • Biochemistry / Clinical Chemistry Testing Automated clinical chemistry testing using modern high-specification technology systems ensuring speed and reliability across the full spectrum of clinical chemistry analyses.
  • Hematology Testing Hematological testing using automatic analyzers and coagulation analyzers with high-performance liquid chromatography (HPLC) as reference method, ensuring high reliability particularly important in clinical diagnosis.
  • Cytology Testing Cytological examinations including PAP test and thin Prep vaginal/endocervical smears, urine cytology, sputum cytology, breast secretions, and fine needle aspiration (FNA) of the thyroid.
  • Hormonology Testing Hormonal analyses for monitoring normal function of endocrine glands and diseases related to them, executed in high daily volumes.
  • Immunology / Virology Testing Diagnostic immunology and virology testing using modern equipment and techniques including immunofluorescence, ELISA, nephelometry, immunochromatography, and agglutination reactions.
  • Molecular Biology Testing Specialized diagnostic tests in a fully equipped Molecular Genetics Department with Biosafety Level II classification, covering prevention, predisposition investigation, early diagnosis, and monitoring of hereditary and infectious diseases.
  • Allergy Testing Allergen testing using the ImmunoCAP reference method from Phadia Laboratory Systems for precise allergy diagnostics.
  • COVID-19 Testing Services Comprehensive COVID-19 testing including RT-PCR molecular testing, rapid antigen testing, antibody testing (IgG, IgM, IgA), neutralizing antibody detection, and cellular immunity testing for SARS-CoV-2.
  • Sample Transportation Service Transportation of biological samples using company-owned vehicles with refrigerated chambers following UN3373 safety transport rules, supporting partner laboratory and clinic network operations.

Quantifiable outcome

  • Fast turnaround times achieved through automated robotic systems and computerized interface with partner laboratories
  • +1 more outcomes

Companies that use Central Lab

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Central Lab technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Central Lab partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core.

  • SIEMENScoreTechnology or IntegrationEquipment manufacturer partnership for medical technology analyzers. SIEMENS provides laboratory diagnostic equipment supporting the lab's automated testing capabilities.
  • ROCHEcoreTechnology or IntegrationEquipment manufacturer partnership for medical technology analyzers. ROCHE provides diagnostic systems for clinical chemistry and other testing.
  • BIORADcoreTechnology or IntegrationEquipment and quality control supplier. Provides analyzers and external quality control protocols (BIORAD, UK NEQAS, INSTAND EV).
  • SEBIAcoreTechnology or IntegrationEquipment manufacturer partnership for medical technology analyzers for electrophoresis and hemoglobin testing.
  • SNIBEcoreTechnology or IntegrationEquipment manufacturer partnership for medical technology analyzers.
  • EUROIMMUNcoreTechnology or IntegrationEquipment manufacturer partnership for autoimmune and infectious disease testing systems.
  • THERMO FISHER SCIENTIFICcoreTechnology or IntegrationEquipment manufacturer partnership for laboratory technology solutions including allergy testing (ImmunoCAP via Phadia).
  • Phadia Laboratory SystemscoreTechnology or IntegrationProvider of ImmunoCAP reference method for allergy testing - the gold standard for allergen-specific IgE testing.
  • CRO CompaniescoreStrategic or Co-development PartnerClinical research organizations collaborating with Central Lab for phase I-IV clinical trials. Lab provides specialized testing including ISO15189 accredited analyses.
  • Pharmaceutical CompaniescoreStrategic or Co-development PartnerGreek and multinational pharmaceutical companies engaged in clinical research partnerships with Central Lab for laboratory diagnostic services.
  • Hospital Research CenterscoreStrategic or Co-development PartnerGreek hospital research centers collaborating on clinical studies requiring specialized laboratory testing.
  • Medical Diagnostic CenterscoreChannel Partner/ Reseller/ DistributorNetwork of medical diagnostic centers referring samples to Central Lab for specialized testing. Computerized interface for seamless operations.
  • Microbiology LaboratoriescoreChannel Partner/ Reseller/ DistributorPartner microbiology labs referring samples for specialized testing. Includes use of modern techniques per CLSI, EUCAST, WHO standards.
  • University ClinicscoreChannel Partner/ Reseller/ DistributorAcademic medical center partners requiring specialized laboratory diagnostics and research support.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Central Lab competitors and assessment

Company assessment

Broad incumbents

  • Affidea: Pan-European diagnostics and outpatient imaging operator with significant Greek presence. Comparable in offering clinical lab and imaging services but operates at much larger scale and as part of a multinational platform.
  • Synlab: Europe's largest clinical laboratory services provider with presence across multiple European markets. Comparable in core reference laboratory services, clinical trial central lab work, and broad test catalog — but operating at vastly greater scale.
  • Eurofins Clinical Diagnostics: Global clinical diagnostics and specialty testing group. Comparable in offering esoteric reference testing, clinical trial support, and infectious disease diagnostics, though as part of a much larger international testing platform.
  • Euromedica: Greek healthcare group operating diagnostic laboratories, clinics, and hospitals. Comparable in providing central lab services to partner sites and direct patients but within a broader healthcare delivery portfolio.
  • Unilabs: Major European clinical diagnostics and specialty testing provider. Comparable in offering routine and esoteric testing, clinical trial central lab services, and partner-based sample collection, though with broader European footprint.

Direct peers

  • Iatropolis: Greek diagnostic laboratory network offering routine and specialized clinical testing with partner sample collection across multiple regions. Comparable operating model with broader geographic coverage and consumer brand recognition.
  • Bioiatriki: Largest Greek diagnostic laboratory chain offering clinical chemistry, microbiology, immunology, and molecular testing with extensive partner network and multi-region footprint. Directly comparable business model (central lab + partner sample collection) but with significantly greater scale and geographic reach.
  • LabO Athens: Greek diagnostic laboratory offering a broad test catalog and partner network model similar to Central Lab. Directly comparable in scale and Attica focus, with similar mix of clinical chemistry, immunology, and molecular testing.
  • Diagnostiki Athinon: Athens-based diagnostic laboratory providing comprehensive clinical testing services including biochemistry, microbiology, hematology, and molecular diagnostics. Closest peer in geographic focus and service scope within the Attica market.

Regional players

  • Mediterranean Hospital of Cyprus (laboratory services): Hospital-based diagnostic laboratory in Cyprus with comparable service scope (biochemistry, microbiology, immunology, molecular biology). Regionally adjacent rather than directly competing, useful as a Southern EU/Mediterranean peer reference for Central Lab's clinical trial ambitions.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Central Lab social profiles

Digital presence

Central Lab compliance and trust

Trust signal

Compliance4 records

Central Lab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Central Lab leadership team

Management profile

Number of profiles

Profiles1 record

Central Lab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Central Lab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Central Lab

What does Central Lab do?

Central Lab is a private clinical and molecular genetics laboratory in Greece offering diagnostic testing across microbiology, biochemistry, hematology, cytology, hormonology, immunology/virology, molecular biology, and allergy disciplines, supported by automated robotic analyzers and a Biosafety II molecular genetics department. It serves as a reference laboratory to partner diagnostic centers, university clinics, microbiology labs, pharmaceutical companies, and CROs through refrigerated sample transport, and also provides direct walk-in testing to individual patients including comprehensive COVID-19 services.

Is Central Lab a public or private company?

Central Lab is a private company. It is classified as management employee owned and is currently operating.

When was Central Lab founded?

Central Lab was founded in 2015. It employs 1 to 10 people.

Where is Central Lab based?

Central Lab is headquartered in Nea Chalkidona, Greece, in the Europe region.

How does Central Lab make money?

One revenue line is on record: clinical Laboratory Diagnostic Testing.

Who are Central Lab's main competitors?

Broad incumbents on record are Affidea, Synlab, Eurofins Clinical Diagnostics, Euromedica and Unilabs. Direct peers are Iatropolis, Bioiatriki, LabO Athens and Diagnostiki Athinon. Mediterranean Hospital of Cyprus (laboratory services) is listed as a regional player.

Does Central Lab have an API?

No public API is recorded for Central Lab.

What industry is Central Lab in?

Central Lab's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales